Fitch Kathryn, Bochner Andrew, Keller Deborah S
a Milliman , New York , NY , USA.
b LLP LTD, Department of Surgery , Houston Methodist Hospital , Houston , TX , USA.
Curr Med Res Opin. 2017 Jul;33(7):1215-1221. doi: 10.1080/03007995.2017.1310719. Epub 2017 Apr 21.
Laparoscopic colectomy has been shown to be safe, oncologically comparable, and clinically beneficial over open colectomy for colon cancer, but utilization remains low. Objectives To evaluate the cost of laparoscopic colectomy vs open colectomy for colon cancer.
The authors conducted a retrospective claims data analysis using the 2012 and 2013 Truven Health Analytics MarketScan Commercial Claims and Encounter Database. The denominator population consisted of individuals who had commercial insurance coverage in all months of 2012 and >1 month in 2013 and pharmacy coverage throughout eligibility. The study population included individuals aged 18-64 years who were identified with colon cancer in 2013 and underwent an elective inpatient open colectomy or laparoscopic colectomy between January and November 2013. The cost and re-admission rate of open vs laparoscopic colectomy were compared after risk, adjusting for comorbidities, demographics, and geographic region.
During the study period, 1299 elective inpatient colon cancer colectomies were performed (open, n = 558; laparoscopic, n = 741). After risk adjustment, the laparoscopic vs open group was shown to have lower re-admission rates (6.61 and 10.93 per 100 cases, respectively, p = .0165), lower average re-admission costs ($1676 and $3151, respectively, p = .0309), and lower 30-day post-discharge healthcare utilization costs ($4842 and $7121, respectively, p = .0047). Average allowed cost for the combined inpatient and 30-day post-discharge period was lower for laparoscopic vs open colectomy cases ($36,395 and $44,226, respectively, p < .001).
The cost of laparoscopic colectomy was found to be statistically significantly less than that of open colectomy in patients undergoing elective surgery for colon cancer.
腹腔镜结肠切除术已被证明是安全的,在肿瘤学方面与开放结肠切除术相当,并且对结肠癌患者具有临床益处,但该手术的利用率仍然较低。目的:评估腹腔镜结肠切除术与开放结肠切除术治疗结肠癌的成本。
作者使用2012年和2013年Truven Health Analytics MarketScan商业保险理赔和病历数据库进行了一项回顾性理赔数据分析。分母人群包括在2012年全年和2013年超过1个月有商业保险覆盖且在整个资格期间有药房保险的个人。研究人群包括2013年确诊为结肠癌且在2013年1月至11月期间接受择期住院开放结肠切除术或腹腔镜结肠切除术的18至64岁个体。在对合并症、人口统计学和地理区域进行风险调整后,比较开放结肠切除术与腹腔镜结肠切除术的成本和再入院率。
在研究期间,共进行了1299例择期住院结肠癌结肠切除术(开放手术,n = 558;腹腔镜手术,n = 741)。经过风险调整后,腹腔镜组与开放组相比,再入院率较低(分别为每100例6.61例和10.93例,p = 0.0165),平均再入院成本较低(分别为1676美元和3151美元,p = 0.0309),出院后30天的医疗保健利用成本较低(分别为4842美元和7121美元,p = 0.0047)。腹腔镜结肠切除术病例的住院和出院后30天综合平均允许成本低于开放结肠切除术病例(分别为36,395美元和44,226美元,p < 0.001)。
对于接受择期结肠癌手术的患者,腹腔镜结肠切除术的成本在统计学上显著低于开放结肠切除术。